Morning Watchlist

    This Obesity Stock Could Soar in 2025 - 2/20

    Ian Cooper
    Thursday, February 20, 20254 min read
    This Obesity Stock Could Soar in 2025 - 2/20








    Company: Viking Therapeutics (SYM: VKTX)


    Keep an eye on Viking Therapeutics (SYM: VKTX).


    Oversold at $33.84, the stock could come back strong with the company nearing Phase 3 trials for its injectable VK2735 for weight loss.  It’s also expected to start Phase 2 trials for its oral formulation, with data expected in the second half of 2025.


    What’s encouraging about VK2735 is that trial results show it’s outperforming other products already on the market. 


    For example, as noted by Seeking Alpha, “Semaglutide (Wegovy) only showed an 8% loss after 20 weeks, while tirzepatide (Zepbound) took significantly longer to reach a larger weight loss. According to a new study, the weight losses from these GLP-1s on the market was far lower than the Viking Therapeutics drug candidate.”


    With exemplary results like that, so far, Viking Therapeutics could have a potential blockbuster hit on its hands with eventual approval from the US FDA. Keep reading for more info...



    Investors Alley


    Act by Feb. 20th, to collect this 22% dividend

    clock


    Warren Buffett has been quietly amassing a massive position in oil stocks: Over $29 billion invested in just two companies. Recently added another $245.7 million to his energy holdings. Now 10% of Berkshire's portfolio is in oil. Clearly, the Oracle of Omaha sees something big coming in energy... But while Buffett's picks pay modest dividends, we've found a way for regular investors to potentially earn a much bigger income stream from the energy boom. A specialized ETF that: Currently yields 22% annually. Pays dividends monthly.


    Click HERE to get the full story to smarter income investing.











    In addition, the company reported that the injectable form of its VK2735 treatment helped patients lose up to 13.1% of their weight after 13 weeks in Phase 2 trials. 


    “The drug at a 15 mg dose showed up to 13.1% placebo-adjusted mean weight loss (14.7% from baseline) observed after only 13 weeks of treatment. After just 13 weeks, VK2735 showed competitive results against weight loss agents tested for longer periods,” added Seeking Alpha.


    The company also said the oral form of VK2735 helped lead to weight loss of about 3.3% of body weight after 28 days in Phase 1 trials. With that result, the company now has plans to initiate its Phase 2 oral drug trial later this year.

    (More info below ad)




    Trading Whisperer


    This Undervalued Stock Is Making Waves

    boat


    Imagine gliding across the water with zero emissions and unmatched efficiency.


    That’s the promise of electric boating, a market projected to skyrocket to $22.31 billion by 2033.


    A revolutionary powertrain is leading the charge, breaking speed records while delivering incredible performance and eco-friendliness.


    This under-the-radar company has partnered with industry giants and is ramping up production to meet growing global demand.


    Learn why this could be the next big breakthrough in sustainable travel.


    Uncover the name and symbol right here.








    We also have to consider the obesity market opportunity is substantial.


    As noted by Goldman Sachs, the global obesity treatment market could grow to $130 billion by 2030. Even Morgan Stanley expects the global obesity drug treatment market to reach $105 billion by 2030 from $77 billion. At the high end, $144 billion.


    Plus, there may be no shortage of demand.


    That’s because, according to the World Health Organization, obesity has more than doubled since 1990. Adolescent obesity has quadrupled. In addition, about 390 million children and adolescents aged five to 19 years were overweight in 2022, including 160 million who were living with obesity.



    Crypto 101


    FREE Report: Top 4 Gold Stocks Ready to Surge in 2025The Most Important AI Token of Q1 2025


    Bitcoin has smashed through $100,000 as Trump's victory ignited the markets. There’s so much hype right now that many are actually forgetting about one of the hottest types of altcoins…


    AI progress hasn’t slowed – it’s actually speeding up, with many new models expected to be released in the upcoming weeks and months. We expect that this PLUS the current hot crypto market could be the recipe for life-changing gains.


    We've identified what could be the most explosive AI opportunity of 2025 – a token that's becoming absolutely essential infrastructure for the entire artificial intelligence industry.


    Discover our #1 AI crypto for the market right now! (We expect this to surge soon.)

    Found this helpful? Share it with others.

    Written by Ian Cooper

    Our Flagship Publication

    Discover Great Companies Trading at a Discount

    Join Behind the Markets